Holen Sie sich die Stockscreener-App
9.78
2.62%
0.25
Handel nachbörslich:
9.78
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Chipmakers Recap: Can IONQ lead its sector in growthMarket Growth Summary & Daily Stock Trend Reports - baoquankhu1.vn
Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Potential 134% Upside in the Healthcare Sector - DirectorsTalk Interviews
Will Delcath Systems Inc. stock recover faster than peersTrade Analysis Summary & Daily Entry Point Trade Alerts - mfd.ru
Is Delcath Systems Inc. stock a safe investment in uncertain marketsMarket Risk Report & Fast Exit/Entry Strategy Plans - mfd.ru
Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com
Clear Street raises Delcath Systems, Inc. (DCTH) target to $29, maintains buy rating - MSN
Technical Reactions to DCTH Trends in Macro Strategies - Stock Traders Daily
Does The Market Have A Low Tolerance For Delcath Systems, Inc.'s (NASDAQ:DCTH) Mixed Fundamentals? - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Compelling 144.88% Upside Potential - DirectorsTalk Interviews
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call - BioSpace
Is Delcath Systems Inc. a strong candidate for buy and hold2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating - Insider Monkey
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Fund Flows: Is Delcath Systems Inc subject to activist investor interestWeekly Investment Report & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (DCTH) Edition - Stock Traders Daily
Canaccord Genuity Sticks to Their Buy Rating for Delcath Systems (DCTH) - The Globe and Mail
The Robot Revolution Is Here: Stocks to Consider from Tesla, Hyundai, and Others. - Intellectia AI
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Delcath Systems Faces Valuation Shift Amidst Mixed Financial Indicators and Growth Trends - Markets Mojo
Aug Gainers: Can Delcath Systems Inc continue delivering strong returns2025 Year in Review & Capital Efficient Trade Techniques - baoquankhu1.vn
Can Delcath Systems Inc. continue delivering strong returnsJuly 2025 Closing Moves & Safe Entry Momentum Tips - mfd.ru
Liver cancer-focused Delcath joins BTIG MedTech, digital health conference - Stock Titan
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance
(DCTH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Analysis Recap: Is CYCCP forming a double bottomMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Retail Surge: Can Delcath Systems Inc continue delivering strong returnsQuarterly Portfolio Review & Consistent Return Investment Signals - baoquankhu1.vn
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Analysis: A 103% Upside Potential In Medical Devices - DirectorsTalk Interviews
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 21, 2026 - BioSpace
Delcath Systems, Inc. announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Is Delcath Systems Inc backed by strong institutional buyingLong Setup & Daily Growth Stock Investment Tips - baoquankhu1.vn
UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver : Newsroom - UT Southwestern
Market Catalysts: Is ODYS forming a bullish divergenceEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Price-Driven Insight from (DCTH) for Rule-Based Strategy - Stock Traders Daily
Delcath Systems expects FY revenue of $85.2 million - MSN
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Reports Strong Preliminary 2025 Results - TipRanks
NY-based Delcath Systems expects Q4 2025 revenue to hit USD 20.7M - Medical Buyer
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - MSN
EBITDA per share of Delcath Systems, Inc. – DUS:DV3R - TradingView — Track All Markets
Delcath reports $85.2 million in 2025 revenue, strong cash position By Investing.com - Investing.com Nigeria
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
DCTH FinancialsIncome Statement - Quiver Quantitative
DCTH: HC Wainwright Reiterates Buy Rating with $30 Price Target - GuruFocus
HC Wainwright Reaffirms Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
0.50%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):